Endothelium-dependent and endothelium-independent effects of 1-nitro-2-propylbenzene on rat aorta.


Journal

Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 28 12 2018
revised: 22 03 2019
accepted: 18 04 2019
pubmed: 24 4 2019
medline: 14 4 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

A group of nitro compounds contains a benzene ring in a short aliphatic chain with the NO

Identifiants

pubmed: 31012153
doi: 10.1111/fcp.12475
doi:

Substances chimiques

Nitro Compounds 0
Vasodilator Agents 0
NG-Nitroarginine Methyl Ester V55S2QJN2X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

612-620

Subventions

Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil
ID : 001
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Informations de copyright

© 2019 Société Française de Pharmacologie et de Thérapeutique.

Références

Brito T.S., Lima F.J., Aragão K.S. et al. The vasorelaxant effects of 1-nitro-2-phenylethane involve stimulation of the soluble guanylate cyclase-cGMP pathway. Biochem. Pharmacol. (2013) 85 780-788.
Fehler M., Broadley K.J., Ford W.R., Kidd E.J. Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine. Naunyn Schmiedebergs Arch. Pharmacol. (2010) 382 385-398.
Brito T.S., Batista-Lima F.J., Gadelha K.K., da Fonseca-Magalhães P.A., Lahlou S., Magalhães P.J. Vasorelaxant effects of 2-nitro-1-phenyl-1-propanol in rat aorta. Clin. Exp. Pharmacol. Physiol. (2016) 43 1054-1061.
Brito T.S., Batista-Lima F.J., de Siqueira R.J.B., Cosker F., Lahlou S., Magalhães P.J.C. Endothelium-independent vasodilator effect of 2-nitro-1-phenyl-1-propanol on mesenteric resistance vessels in rats. Eur. J. Pharmacol. (2017) 806 52-58.
Bravo E.L. Phenylpropanolamine and other over-the-counter vasoactive compounds. Hypertension (1988) 11(3 Pt 2) II7-II10.
Vasconcelos T.B., Ribeiro-Filho H.V., Lahlou S., Pereira J.G.C., Oliveira P.S.L., Magalhães P.J.C. Vasodilator effects and putative guanylyl cyclase stimulation by 2-nitro-1-phenylethanone and 2-nitro-2-phenyl-propane-1,3-diol on rat aorta. Eur. J. Pharmacol. (2018) 830 105-114.
Perrin-Sarrado C., Dahboul F., Leroy P., Lartaud I. Aging and hypertension decrease endothelial NO-related dilating function and gamma-glutamyl transferase activity but not S-nitrosoglutathione-induced aortic vasodilation. Fundam. Clin. Pharmacol. (2018) 32 134-140.
Arruda-Barbosa L., Rodrigues K.M., Souza-Neto F. et al. Vasorelaxant effects of 1-nitro-2-phenylethene in rat isolated aortic rings. Vascul. Pharmacol. (2014) 63 55-62.
Arruda-Barbosa L., Lahlou S., Magalhães P.J. et al. Trans-4-methoxy-β-nitrostyrene relaxes rat thoracic aorta through a sGC-dependent pathway. Eur. J. Pharmacol. (2017) 807 182-189.
Teófilo T.M., Arruda-Barbosa L., Rodrigues-Silva J.M. et al. Mechanism of the vasorelaxant effect induced by trans-4-methyl-β-nitrostyrene, a synthetic nitroderivative, in rat thoracic aorta. Clin. Exp. Pharmacol. Physiol. (2017) 44 787-794.
Santos S.E., Ribeiro F.P.R.A., Menezes P.M.N. et al. New insights on relaxant effects of (-)-borneol monoterpene in rat aortic rings. Fundam. Clin. Pharmacol. (2019) 33 148-158.
Rees D.D., Palmer R.M., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. (1990) 101 746-752.
Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. (1995) 48 184-188.
de Siqueira R.J., Magalhães P.J., Leal-Cardoso J.H., Duarte G.P., Lahlou S. Cardiovascular effects of the essential oil of Croton zehntneri leaves and its main constituents, anethole and estragole, in normotensive conscious rats. Life Sci. (2006) 78 2365-2372.
Soares P.M., Lima R.F., de Freitas Pires A., Souza E.P., Assreuy A.M., Criddle D.N. Effects of anethole and structural analogues on the contractility of rat isolated aorta: involvement of voltage-dependent Ca2 + -channels. Life Sci. (2007) 81 1085-1093.
López R.M., Pérez T., Castillo C., Castillo E.F. Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study. Fundam. Clin. Pharmacol. (2011) 25 313-322.
Budzyn K., Marley P.D., Sobey C.G. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension. J. Pharmacol. Exp. Ther. (2005) 313 1248-1253.
Detremmerie C., Vanhoutte P.M., Leung S. Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone. Acta Pharm. Sin. B. (2017) 7 401-408.
Tang E.H., Ku D.D., Tipoe G.L., Feletou M., Man R.Y., Vanhoutte P.M. Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/- knockout but not COX1-/- knockout mice. J. Cardiovasc. Pharmacol. (2005) 46 761-765.
Coupar I.M. Prostaglandin action, release and inactivation by rat isolated perfused mesenteric blood vessels. Br. J. Pharmacol. (1980) 68 757-763.
Nagata K., Duggan A., Kumar G., García-Añoveros J. Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J. Neurosci. (2005) 25 4052-4061.
McNamara C.R., Mandel-Brehm J., Bautista D.M. et al. TRPA1 mediates formalin-induced pain. Proc. Natl Acad. Sci. USA (2007) 104 13525-13530.
Earley S. TRPA1 channels in the vasculature. Br. J. Pharmacol. (2012) 167 13-22.
Peixoto-Neves D., Wang Q., Leal-Cardoso J.H., Rossoni L.V., Jaggar J.H. Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels. Br. J. Pharmacol. (2015) 172 3484-3494.

Auteurs

Thiago Brasileiro Vasconcelos (TB)

Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil.

Helder Veras Ribeiro-Filho (HV)

Brazilian Biosciences National Laboratory (LNBio), Campinas, Brazil.

Emanuella Feitosa Carvalho (EF)

Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil.

Teresinha Silva Brito (TS)

Federal Rural University of the Semi-arid Region, Mossoró, Brazil.

Saad Lahlou (S)

Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil.

Pedro Jorge Caldas Magalhães (PJC)

Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH